Tag Archive | "Pharmaxis"

Boehringer Ingelheim acquires Pharmaxis’ anti-inflammatory candidate

Tags: ,


Boehringer Ingelheim exercises option and acquires global ownership of Pharmaxis’ investigational anti-inflammatory drug candidate PXS4728A, including associated intellectual property rights. Read the full story